Rockwell Medical Inc.
RMTI | NASDAQ
$8.69
-$0.01 (-0.11%)
Sep 22, 2026, 2:15 PM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | 69.26M | 101.49M | 83.61M | 72.81M | 61.93M | 62.2M |
Cost of Revenue | 57.56M | 84.01M | 74.91M | 68.73M | 64.35M | 59.47M |
Gross Profit | 11.7M | 17.48M | 8.7M | 4.08M | -2.42M | 2.73M |
Operating Income | -4.69M | 608K | -6.67M | -16.78M | -30.34M | -28.42M |
Interest Income | 234K | 92K | 211K | 33K | 22K | 238K |
Pretax Income | -5.31M | -480K | -8.44M | -18.68M | -32.67M | -30.89M |
Net Income | -5.31M | -480K | -8.44M | -18.68M | -32.67M | -30.89M |
Selling & General & Admin | 16.39B | 16.86M | 14.27M | 17.74M | 21.08M | 24.05M |
Research & Development | n/a | 19K | 1.11M | 3.12M | 6.84M | 7.09M |
Other Expenses | -16.37B | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 16.39M | 16.88M | 15.37M | 20.86M | 27.92M | 31.15M |
Interest Expense | 1.12M | 1.25M | 2.3M | 1.94M | 2.36M | 1.88M |
Selling & Marketing Expenses | 2.35B | 2.75M | 2.13M | 2.09M | 5.73M | 7.87M |
Cost & Expenses | 73.95M | 100.88M | 90.28M | 89.59M | 92.27M | 90.62M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 3.6M | 3.11M | 2.33M | 986.68K | 852.62K | 687.47K |
Shares Outstanding (Diluted) | 3.6M | 3.11M | 2.33M | 986.68K | 852.62K | 687.47K |
EPS (Basic) | -1.50 | -0.25 | -3.60 | -18.90 | -38.30 | -44.90 |
EPS (Diluted) | -1.50 | -0.25 | -3.60 | -18.90 | -38.30 | -44.90 |
EBITDA | -2M | 2.95M | -4.69M | -16.17M | -27.8M | -26.72M |
EBIT | -4.19M | 774K | -6.14M | -16.74M | -30.31M | -29.01M |
Depreciation & Amortization | 2.19M | 2.18M | 1.44M | 576K | 2.52M | 2.29M |
Add to Watchlist
Select watchlists to add or remove RMTI